Mark A. Goldsmith, See Remarks at Revolution Medicines, Inc. (RVMD), sold 25,742 shares at $99.48 ($2.6M) on 2026-03-17, disclosed to the SEC on 2026-03-19.
Scheduled sale ($2.6M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.48 | 12,871 | $1.3M | 50.0% |
| 2 | $99.48 | 12,871 | $1.3M | 50.0% |
| Total | $99.48 avg | 25,742 | $2.6M | 100% |
| Filing → |
| RVMD | SELL | 2026-06-18 | $1.6M | — | Filing → |
| RVMD | SELL | 2026-04-17 | $18.0M | — | Filing → |
| RVMD | SELL | 2026-03-03 | $7.2M | — | Filing → |